The University of Nottingham Medical School is the medical school of the University of Nottingham, Nottingham, UK. Its first intake of 48 students graduated in 1975.

During the past decade, Queen's Medical Centre conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 24 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 13 clinical trials were completed. i.e. 37.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Medical Centre" #1 sponsor was "Children's Cancer and Leukaemia Group" with 32 trials, followed by "University of Nottingham" with 17 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "University of Birmingham" with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Medical Centre" #1 collaborator was "National Institute for Health Research, United Kingdom" with 8 trials as a collaborator, "The Leeds Teaching Hospitals NHS Trust" with 5 trials as a collaborator, "Queen Mary University of London" with 4 trials as a collaborator, "University of Cambridge" with 4 trials as a collaborator and "University of Edinburgh" with 4 trials as a collaborator. Other collaborators include 172 different institutions and companies that were collaborators in the rest 144 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Medical Centre" are "Brain and Central Nervous System Tumors" (18 trials), "Neuroblastoma" (8 trials), "Sarcoma" (7 trials), "Colorectal Cancer" (5 trials) and "Cystic Fibrosis" (5 trials). Many other conditions were trialed in "Queen's Medical Centre" in a lesser frequency.

Most popular intervention types in "Queen's Medical Centre" are "Drug" (106 trials), "Procedure" (44 trials), "Radiation" (26 trials), "Other" (19 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "radiation therapy" (22 trials), "carboplatin" (17 trials), "vincristine sulfate" (17 trials) and "conventional surgery" (16 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Medical Centre" are 160 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 34 active trials in "Queen's Medical Centre". 1 are not yet recruiting, 22 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 78 completed trials in Queen's Medical Centre, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Medical Centre, 7 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 30 trials that are defined as “Not Applicable".